Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Acro Biomedical (ACBM) Return on Equity (2017 - 2025)

Acro Biomedical (ACBM) has 9 years of Return on Equity data on record, last reported at 0.25% in Q4 2025.

  • For Q4 2025, Return on Equity rose 10.0% year-over-year to 0.25%; the TTM value through Dec 2025 reached 0.25%, up 10.0%, while the annual FY2025 figure was 0.3%, 14.0% up from the prior year.
  • Return on Equity reached 0.25% in Q4 2025 per ACBM's latest filing, down from 0.41% in the prior quarter.
  • Across five years, Return on Equity topped out at 35.47% in Q4 2023 and bottomed at 254.38% in Q3 2023.
  • Average Return on Equity over 5 years is 17.69%, with a median of 0.98% recorded in 2021.
  • Peak YoY movement for Return on Equity: tumbled -23617bps in 2023, then surged 25455bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 2.67% in 2021, then tumbled by -1113bps to 32.44% in 2022, then surged by 209bps to 35.47% in 2023, then tumbled by -100bps to 0.15% in 2024, then skyrocketed by 69bps to 0.25% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.25% in Q4 2025, 0.41% in Q3 2025, and 0.15% in Q2 2025.